SEC Form 4 · accession 0001472343-15-000073
Roka BioScience, Inc. · ROKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Doyle
Director
Period of report
Jun 24, 2015
Accepted (ET)
Jun 26, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472343
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.75 | Jun 24, 2015 | A | 15,000 | A | — | Jun 23, 2025 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Such stock options vest in 1/36th increments on a monthly basis beginning one month after the grant date. The stock options have a term of ten years.